source,destination,score,evidence
hsa-miR-4723-5p,pilocytic astrocytoma cancer,0.98138427734375,Unconfirmed
hsa-miR-552-3p,Duke C cancer,0.9805506467819214,Unconfirmed
hsa-miR-4417,HPV positive cancer,0.9803490042686462,Unconfirmed
hsa-miR-520a-5p,HPV negative cancer,0.9790224432945251,Unconfirmed
hsa-miR-548d-3p,nasopharyngeal cancer,0.9788666367530823,Unconfirmed
hsa-miR-138-5p,combined hepatocellular cholangiocarcinoma cancer,0.9653323888778687,Unconfirmed
hsa-miR-627-3p,oral squamous cell carcinoma,0.9591643810272217,Unconfirmed
hsa-miR-26b*,anaplastic astrocytoma cancer,0.9536372423171997,Unconfirmed
hsa-miR-3182,PR positive cancer,0.9524154663085938,Unconfirmed
hsa-miR-183,rhabdomyosarcomas cancer,0.9476643204689026,miR2Disease
hsa-miR-6749-5p,testicular germ cell tumor cancer,0.9463692903518677,Unconfirmed
hsa-miR-125b-2-3p,colorectal adenocarcinoma cancer,0.9463455080986023,Unconfirmed
hsa-miR-6846-5p,B cell lymphoma of MALT type cancer,0.9456773400306702,Unconfirmed
hsa-miR-6785-3p,hepatocellular carcinoma,0.9449623823165894,Unconfirmed
hsa-miR-3156-5p,primary papillary thyroid carcinomas cancer,0.9425151348114014,Unconfirmed
hsa-miR-183*,esophageal cancer,0.9420753121376038,Unconfirmed
hsa-miR-6073,kidney renal papillary cell carcinoma cancer,0.9406068921089172,Unconfirmed
hsa-miR-5002-3p,colorectal adenoma cancer,0.9395071864128113,Unconfirmed
hsa-miR-92a-1-5p,serous ovarian cancers cancer,0.9313115477561951,Unconfirmed
hsa-miR-27a-5p,papillary thyroid carcinoma cancer,0.911946177482605,Unconfirmed
hsa-miR-23a-3p,cholangiocarcinoma cancer,0.8958964347839355,Unconfirmed
hsa-miR-187-3p,cholangiocellular carcinoma cancer,0.8954943418502808,Unconfirmed
hsa-miR-517c-3p,HER2+ positive cancer,0.8876219391822815,Unconfirmed
hsa-miR-497-3p,esophageal squamous cell carcinomas cancer,0.8873338103294373,Unconfirmed
hsa-miR-769-3p,acute myelogenous leukemia cancer,0.8849387764930725,miR2Disease
hsa-miR-18a,uterine corpus endometrial carcinoma cancer,0.8825170397758484,miR2Disease
hsa-miR-455-5p,uterus cancer,0.8809904456138611,Unconfirmed
hsa-miR-518f-3p,cutaneous T-cell lymphoma cancer,0.8690286874771118,Unconfirmed
hsa-miR-6813-5p,tubulovillous adenoma cancer,0.8669196963310242,Unconfirmed
hsa-miR-148b,colon adenocarcinoma cancer,0.8599622249603271,miR2Disease
hsa-miR-4687-5p,squamous cell carcinoma cancer,0.8576958775520325,Unconfirmed
hsa-miR-6810-5p,B-cell non-Hodgkin lymphoma cancer,0.8576235175132751,Unconfirmed
hsa-miR-623,triple negative cancer,0.8541785478591919,Unconfirmed
hsa-miR-370,infantile hemangioma cancer,0.8520440459251404,miR2Disease
hsa-miR-4279,"Luminal A,triple negative cancer",0.8516817688941956,Unconfirmed
hsa-miR-652,clear cell ovarian carcinoma cancer,0.8461995720863342,miR2Disease
hsa-miR-6851-3p,Leptomeningeal metastasis cancer,0.8355678915977478,Unconfirmed
hsa-miR-144*,adrenocortical carcinoma cancer,0.8320666551589966,miR2Disease
hsa-miR-2355-5p,gastrointestinal stromal tumor,0.8170723915100098,Unconfirmed
hsa-miR-1276,malignant pleural mesothelioma cancer,0.8096504807472229,Unconfirmed
hsa-miR-363,glioblastoma cancer,0.7789592146873474,miR2Disease
hsa-miR-6828-3p,chromophobe renal cell carcinoma cancer,0.7682774066925049,Unconfirmed
hsa-miR-4679,adenocarcinoma cancer,0.7682464718818665,Unconfirmed
hsa-miR-145-5p,small intestinal neuroendocrine tumor,0.7630785703659058,Unconfirmed
hsa-miR-7-5p,melanoma brain metastasis cancer,0.7624555826187134,Unconfirmed
hsa-miR-585-3p,Kaposi's sarcoma cancer,0.7592898607254028,Unconfirmed
hsa-miR-4785,sarcoma,0.7589934468269348,Unconfirmed
hsa-miR-22,bladder cancer,0.757436990737915,miR2Disease
hsa-miR-4476,myeloma cancer,0.7535301446914673,Unconfirmed
hsa-miR-3189-5p,non-small cell lung cancer,0.7528936266899109,Unconfirmed
hsa-miR-6124,ovarian carcinoma cancer,0.7524276971817017,Unconfirmed
hsa-miR-488-5p,skin cutaneous melanoma cancer,0.7493579387664795,Unconfirmed
hsa-miR-659-5p,Gastric lymphoma cancer,0.7459787130355835,Unconfirmed
hsa-miR-548e-3p,astrocytoma cancer,0.7456961870193481,Unconfirmed
hsa-miR-26b-3p,H. Pylori negative gastric cancer,0.7428554892539978,Unconfirmed
hsa-miR-4419a,breast invasive carcinoma cancer,0.7419222593307495,Unconfirmed
hsa-miR-3155a,Barrett's carcinogenesis cancer,0.7271072864532471,Unconfirmed
hsa-miR-18b,larynx cancer,0.7179545164108276,miR2Disease
hsa-miR-381,retinoblastoma,0.6913952231407166,miR2Disease
hsa-miR-4771,large cell carcinoma cancer,0.6894973516464233,Unconfirmed
hsa-miR-6815-3p,chronic lymphocytic leukemia cancer,0.6858866810798645,Unconfirmed
hsa-miR-3193,invasive lobular carcinoma cancer,0.6773104667663574,Unconfirmed
hsa-miR-374a,medullary thyroid cancer,0.6759244203567505,Unconfirmed
hsa-miR-93,chordoma,0.6717487573623657,miR2Disease
hsa-miR-6815-5p,hepatoblastoma cancer,0.6716554164886475,Unconfirmed
hsa-miR-7975,oropharyngeal squamous cell carcinoma,0.6702523827552795,Unconfirmed
hsa-miR-6869-5p,prostate adenocarcinoma cancer,0.6647868752479553,Unconfirmed
hsa-miR-139-5p,B acute lymphoblastic leukemia cancer,0.6544565558433533,miR2Disease
hsa-miR-6778-5p,cervical squamous cell carcinoma cancer,0.6539741158485413,Unconfirmed
hsa-miR-3912-5p,colon cancer,0.6533766984939575,Unconfirmed
hsa-miR-589-5p,colonic adenomas cancer,0.6525779962539673,Unconfirmed
hsa-miR-4732-3p,B cell lymphoma cancer,0.646259605884552,Unconfirmed
hsa-miR-3152-5p,osteosarcoma cancer,0.6350487470626831,Unconfirmed
hsa-miR-33b-3p,aryngeal squamous cell carcinoma cancer,0.6299393773078918,Unconfirmed
hsa-miR-423-5p,diffuse large B cell lymphoma cancer,0.6274380087852478,Unconfirmed
hsa-miR-362-3p,follicular thyroid carcinoma cancer,0.6206580996513367,Unconfirmed
hsa-miR-1281,esophageal carcinoma cancer,0.6153792142868042,Unconfirmed
hsa-miR-6805-5p,Luminal cancer,0.6104497909545898,Unconfirmed
hsa-miR-301a-5p,meningioma cancer,0.6079420447349548,Unconfirmed
hsa-miR-370-3p,glioblastoma  cancer,0.5963771343231201,Unconfirmed
hsa-miR-191,Luminal A cancer,0.5885322690010071,miR2Disease
